Viva Biotech Holdings (VB0) — Financial Flexibility Index
Viva Biotech Holdings (VB0) has a Financial Flexibility Index of 0.05x as of June 2023. Free cash flow of €209.53 Million (operating CF €158.72 Million minus capex €50.80 Million) represents 0% of total liabilities (€4.51 Billion). Also explore Viva Biotech Holdings (VB0) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Viva Biotech Holdings Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Viva Biotech Holdings across 9 annual periods. Check Viva Biotech Holdings strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Viva Biotech Holdings (2016–2024)
Year-by-year free cash flow to debt coverage for Viva Biotech Holdings. For the full company profile including market capitalisation, see VB0 company net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.17x | €565.66 Million | €373.99 Million | €3.23 Billion | ▲ +15.2% |
| 2023 | 0.15x | €571.24 Million | €383.40 Million | €3.76 Billion | ▲ +3.1% |
| 2022 | 0.15x | €635.38 Million | €386.05 Million | €4.32 Billion | ▼ -5.4% |
| 2021 | 0.16x | €643.01 Million | €77.83 Million | €4.13 Billion | ▲ +7.6% |
| 2020 | 0.14x | €635.80 Million | €43.18 Million | €4.40 Billion | ▼ -82.8% |
| 2019 | 0.84x | €102.20 Million | €46.01 Million | €121.39 Million | ▲ +296.5% |
| 2018 | 0.21x | €59.01 Million | €12.11 Million | €277.90 Million | ▼ -77.5% |
| 2017 | 0.94x | €46.81 Million | €27.89 Million | €49.64 Million | ▼ -16.1% |
| 2016 | 1.12x | €28.46 Million | €21.12 Million | €25.32 Million | — |